Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans

Lancet

Volumn 350, Issue 9091, 1997, Pages 1590-1593

  Smith, O P ^a   White, B ^a   Vaughan, D ^b   Rafferty, M ^a   Claffey, L ^c   Lyons, B ^b   Casey, W ^b  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTEIN C;

ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; FULMINATING PURPURA; HEMODIALYSIS; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LEG AMPUTATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NEISSERIA MENINGITIDIS; NONHUMAN; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN C DEFICIENCY; SCORING SYSTEM; SEPTICEMIA; SKIN GRAFT; THROMBOSIS;

EID: 0031590612     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06356-3     Document Type: Article

References (34)

1. Havens PL, Garland JS, Brook MM, Dewitz BA, Stemski ES, Troshynski TJ. Trends in mortality in children hospitalised with meningococcal infections, 1957 and 1987. Pediatr Infect Dis J 1989; 8: 8-11.
2. Giraud T, Dhainaut JF, Scremmer B, et al. Adult overwhelming meningococcal purpura: a study of 35 cases, 1977-1989. Arch Intern Med 1991; 151: 310-16.
3. McGehee WG, Rapaport SI, Hijort PF. Intravascular coagulation in fulminant meningococcaemia. Ann Intern Med 1967; 67: 250-60.
4. Heyderman RS. Severe sepsis and intravascular thrombosis. Arch Dis Child 1993; 68: 621-25.
5. Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
6. Powars DR, Larsen R, Johnson J, et al. Epidemic meningococcaemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 1993; 17: 254-61.
7. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-46.
8. Branson H, Katx J, Marble R, Griffen JH. Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate. Lancet 1983; ii: 1165-68.
9. Seligsohn U, Berger A, Abend M, et al. Homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-68.
10. Dreyfus M, Magny JF, Bridey F, et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-68.
11. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A. Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of E coli infusion in the baboon. J Clin Invest 1987; 79: 918-25.
12. Taylor F, Chang A, Ferrell G, et al. C4b-Binding Protein exacerbates the host to E coli. Blood 1991; 78: 357-63.
13. Grinnell BW, Hermann RB, Yan SB. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobology 1994; 4: 221-26.
14. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, INFγ, or phorbol ester. J Immunol 1994; 153: 3664-68.
15. Hancock WW, Grey ST, Hau L, et al. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995; 60: 1525-32.
16. Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein-C/activated protein C receptor. J Biol Chem 1994; 269: 26486-91.
17. Waage A, Halstensen A, Espevic T. Association between TNF in serum and fatal outcome in meningococcal disease. Lancet 1987; i: 355-57.
18. Bellomo R, Tipping P, Boyce N. Continous veno-venous haemofiltration with dialysis removes cytokines from the circulation of patients with sepsis. Crit Care Med 1993; 21: 522-26.
19. Best C, Walsh J, Sinclair J, Beattie J. Early haemo-diafiltration in meningococcal septicaemia. Lancet 1995; 347: 202.
20. Pollack MM, Ruttimann UE, Getson PR. Paediatric risk of mortality (PRISM) score. Crit Care Med 1986; 14: 215-21.
21. Thompson APJ, Sills JA, Hart CA. Validation of the Glasgow meningococcal septicaemia prognostic score: a 10 year retrospective survey. Crit Care Med 1991; 19: 26-30.
22. Scully MF, Toh CH, Hoogendoorn H, et al. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, α1-antitrypsin and α2-macroglobulin, in patients with disseminated intravascular coagulation. Thromb Haemost 1993; 69: 448-53.
23. Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63.
24. Brandtzaeg P, Sandset M, Joo GB, Ovstebo R, Kierulf P, Abilgaard U. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic coagulation pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55: 459-70.
25. Esmon CT, Taylor FB Jr, Russell Snow T. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-65.
26. Laszik Z, Esmon CT. The newly identified protein C receptor is present primarily on vascular endothelium of large vessels: implications for the control of the protein C pathway. J Clin Invest (in press).
27. Manios SG, Kanakoudi F, Maniati E. Fulminant meningococcaemia: heparin therapy and survival rate. Scand J Infect Dis 1971; 3: 127-33.
28. Feinstein DI. Diagnosis and management of diseminated intravascular coagulation: the role of heparin therapy. Blood 1982; 60: 284-87.
29. Kuppermann N, Inkelis S, Saladino R. The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr Infect Dis J 1994; 13: 867-87.
30. Heydeman RS, Klein NJ, Shennan GI, Levin M. Modulation of the anticoagulant properties of glycosaminoglycans on the surface of vascular endothelium by endotoxin and neutrophils: evaluation by amidolytic assay. Thromb Res 1992; 67: 677-85.
31. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion inducing cytokines in leucocytes. Immunol Today 1993; 14: 111-15.
32. Daubener W, Nockemann S, Gutsche M, Hadding U. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ. E J Immunol 1995; 25: 688-92.
33. Attanasio M, Gori AM, Giusti B, et al. Cytokine gene expression in human stimulated monocytes is inhibited by heparin. Thromb Haemost 1997; 77 (suppl): 9.
34. Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995; 126: 646-52.